#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Spinal muscular atrophy Non-Hodgkin's lymphoma Pelizaeus-Merzbacher disease Chronic cutaneous lupus erythematosus Neuroblastoma Liver transplant rejection Hereditary spastic paraplegia Staphylococcal infection Medulloblastoma recurrent Gaucher's disease type I Nephropathy Mycobacterium abscessus infection Neurofibroma Cerebral arteriovenous malformation haemorrhagic Haemophilia B with anti factor IX More trials…

    Learn about Rare Diseases

    Mucopolysaccharidosis II – Diagnostics Marginal zone lymphoma – Basic Information Myelodysplastic syndrome with excess blasts – Treatment Factor VIII deficiency – Trials in Disease Hereditary optic atrophy – Treatment Niemann-Pick disease – Trials in Disease Idiopathic inflammatory myopathy – Diagnostics Glycogen storage disease type V – Trials in Disease Adrenocortical carcinoma – Trials in Disease Myelodysplastic syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Regadenoson Trandolapril Alectinib Hydrochloride CITRIC ACID ANHYDROUS Dexamethasone Isonicotinate SKB410 Ibrutinib Doxycycline Hyclate Losmapimod Patiromer Afamitresgene Autoleucel Ranibizumab ANTIMETABOLITES Prucalopride Deflazacort NIZUBAGLUSTAT Betamethasone Dipropionate Escitalopram Oxalate Treg02 Dexrazoxane Hydrochloride More therapies…

    Learn about Your Condition

    Open angle glaucoma Contusion Acute myocardial infarction Endometrial cancer stage IV Drug eruption Glioblastoma multiforme Hypertonic bladder Urethral valves Chorioretinitis Endotracheal intubation Endometrial cancer recurrent Liposarcoma recurrent Atopic keratoconjunctivitis Immunodeficiency congenital Klinefelter's syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on Severe Erythema Multiforme: Comparing Methylprednisolone Acetate and Lidocaine Hydrochloride Monohydrate with Placebo for Hospitalized Patients

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Erythema multiforme
    Investigated Drugs:
    • Lidocaine Hydrochloride Monohydrate
    • Methylprednisolone Acetate
    • Prednisone
    France

  • Study on L-Glutamic Acid and Sodium Chloride to Prevent Acute Kidney Injury in High-Risk Heart Surgery Patients Without Diabetes

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Acute kidney injury
    Investigated Drugs:
    • L-Glutamic Acid
    • Sodium Chloride
    Sweden

  • Study of Propranolol and Vinorelbine for Children and Teenagers with Refractory or Relapsing Solid Tumors

    Not yet recruiting

    1 1 1 1
    Investigated Diseases:
    • Malignant glioma
    • Desmoid tumour
    • Neoplasm malignant
    Investigated Drugs:
    • Vinorelbine Tartrate
    • Propranolol Hydrochloride
    France

  • Study of perioperative versus post-surgery FOLFIRINOX (irinotecan, oxaliplatin, fluorouracil, and folinic acid) treatment in patients with resectable pancreatic cancer

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Pancreatic carcinoma
    Investigated Drugs:
    • Fluorouracil
    • Folinic Acid
    • Irinotecan Hydrochloride Trihydrate
    The Netherlands Sweden

  • Study on Trametinib for Patients with Neurofibromatosis Type 1 and Symptomatic Plexiform Neurofibromas

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Neurofibromatosis
    Investigated Drugs:
    • Trametinib
    The Netherlands

  • Study of Avacopan Safety and Effectiveness in Patients with ANCA-associated Vasculitis

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Anti-neutrophil cytoplasmic antibody positive vasculitis
    Investigated Drugs:
    • Avacopan
    • Azathioprine
    • Cyclophosphamide
    Czechia Denmark France Greece Hungary Poland +1
Previous Page
1 … 853 854 855 856 857 … 1,675
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!